73%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
73%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
73%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
73%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Cencora Inc
Suletud
SektorTervishoid
340.94 0.34
Ülevaade
Aktsiahinna muutus
24h
Min
339.05
Max
341.66
Sissetulek | -1B -340M |
|---|---|
Müük | 3.1B 84B |
P/E Sektori keskmine | 42.717 78.892 |
Aktsiakasum | 3.84 |
Dividenditootlus | 0.65 |
Kasumimarginaal | -0.406 |
Töötajad | 47,000 |
EBITDA | -1.1B 150M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +15.54% upside |
Dividenditootlus Sektori keskmine | 0.65% 2.38% |
|---|
Turukapital | -135M 66B |
|---|---|
Eelmine avamishind | 340.6 |
Eelmine sulgemishind | 340.94 |
Uudiste sentiment
By Acuity
17%
83%
20 / 374 Pingereas Healthcare
Cencora Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Cencora Inc Prognoos
Hinnasiht
By TipRanks
15.54% tõus
12 kuu keskmine prognoos
Keskmine 392.82 USD 15.54%
Kõrge 417 USD
Madal 361 USD
Põhineb 11 Wall Streeti analüütiku instrumendi Cencora Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
20 / 374 Pingereas Tervishoid
Uudiste sentiment
Väga tugevad tõusu märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Cencora Inc
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Live chat